Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 7:48 PM
Ignite Modification Date:
2025-12-24 @ 7:48 PM
NCT ID:
NCT03977103
Eligibility Criteria:
Inclusion Criteria:
* AML and ALL in complete remission and with high-risk of relapse
* AML and ALL primarily chemoresistant or relapsed;
* Chronic Myeloid Leukemia in accelerated or blastic phase;
* Patients affected by
* Multiple myeloma,
* Non Hodgkin lymphoma,
* Hodgkin lymphoma,
* Chronic myeloproliferative syndrome,
* Chronic Lymphoid Leukemia,
* Other Hematological malignancy at high-risk of relapse or detectable disease and where a HSCT is indicated.
* Age \<75 years
* ECOG ≤ 2
* Acceptable lung, liver, kidney, and heart function and absence of relevant psichiatric diseases
* Signature of the informed consent
Exclusion Criteria:
* Age \>75 years
* ECOG \> 2
* Not acceptable lung, liver, kidney, and heart function and presence of relevant psichiatric diseases
* Pregnancy
* No signature of the informed consent
Healthy Volunteers:
False
Sex:
ALL
Maximum Age:
75 Years
Study:
NCT03977103
Study Brief:
Protocol Section:
NCT03977103